Richard Mountfield

Richard Mountfield serves as the Senior Vice President of Regulatory Affairs and Quality at Aura Biosciences, where responsibilities include driving long-term strategies for the company's transition into a commercial entity focused on oncology. Previously, Richard held senior leadership roles at Zenas BioPharma and Constellation Pharmaceuticals, contributing to strategic initiatives and fostering relationships with stakeholders. Richard's extensive experience includes roles at Boston Pharmaceuticals, Celyad, Novartis, Boehringer Ingelheim, Hoffmann-La Roche, and Novo Nordisk A/S, with a strong emphasis on regulatory affairs and drug development across various therapeutic areas. Richard holds a Ph.D. in Biochemistry from Prifysgol Aberystwyth University and a BSc (Hons) in Biochemistry from Coventry University.